Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our customタンパク質 services!
カスタムサービスについてのお問い合わせはこちら >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
|---|---|---|---|---|---|
| DR1-H52P6 | Human | Human DRD1 Full Length Protein (VLP) |
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Docarpamine | TA-870; TA-8704 | Approved | Tanadopa | Heart Failure | null | 1994-01-01 | Heart Failure | Details | ||
| Olanzapine/Fluoxetine hydrochloride | OFC | Approved | Eli Lilly And Company | Symbyax | United States | Bipolar Disorder | Eli Lilly And Company | 2003-12-24 | Depressive Disorder, Major; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Treatment-Resistant | Details |
| Zuclopenthixol Hydrochloride | LU-0108 | Approved | Clopixol | Bipolar Disorder; Schizophrenia | null | 1962-01-01 | Schizophrenia; Bipolar Disorder | Details | ||
| Methylergometrine Maleate | Approved | Metenarin, Methergine, Ryegonivin, Basofortina, Methylergobrevin | Postpartum Hemorrhage; Uterine Cervical Incompetence; Uterine Hemorrhage; Uterine Inertia | Details | ||||||
| Samidorphan/Olanzapine | ALKS-3831 | Approved | Alkermes Plc | Lybalvi | United States | Bipolar Disorder; Schizophrenia | Alkermes Inc | 2021-05-28 | Schizophrenia; Bipolar Disorder; Psychotic Disorders; Bipolar and Related Disorders; Alcoholism | Details |
| Olanzapine | LY-170053; INP-105; TEV-‘749; LY-170052; ALKS-7921 | Approved | Eli Lilly And Company | Zyprexa Relprevv, Olansek, Zyprexa Zydis, Olanzapine ODF, 再普乐, Midax, Lanzac, Zyprexa, Zypadhera, Zalasta, Zyprexa Velotab | EU | Schizophrenia; Bipolar Disorder | null | 1996-09-27 | Opioid-Related Disorders; Chemotherapy-induced nausea and vomiting; Fasting; Anorexia Nervosa; Borderline Personality Disorder; Depressive Disorder, Treatment-Resistant; Gambling; Nausea; Vomiting; Postoperative Nausea and Vomiting; Emergence Delirium; Feeding and Eating Disorders; Malaria, Falciparum; Autistic Disorder; Hematologic Neoplasms; Neoplasms; Insulin Resistance; Anorexia; Bipolar Disorder; Psychotic Disorders; Bipolar and Related Disorders; Depression; Stomach Neoplasms; Depressive Disorder, Major; Schizophrenia; Substance-Related Disorders; Weight Loss; Solid tumours | Details |
| Phenylpropanolamine Hydrochloride | Approved | Nasadec, Nasathera, Pararhinol | Nasal Obstruction | Details | ||||||
| Fenoldopam Mesylate | SKF-82526; SKF-82526J; (±)-SKF-82526 | Approved | Abbott Laboratories | Corlopam | United States | Hypertension | Hospira Inc | 1997-09-23 | Hypertension | Details |
| Olanzapine/Hydroxyzine pamoate | Approved | Nausea | Details | |||||||
| Stepholidine | Approved | Mainland China | Headache; Attention Deficit Disorder with Hyperactivity; Tourette Syndrome; Migraine Disorders | null | 1995-01-01 | Headache; Migraine Disorders; Attention Deficit Disorder with Hyperactivity; Tourette Syndrome | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Ecopipam | PSYRX-101; Sch-39166 | Phase 3 Clinical | Merck Sharp & Dohme Corp | Language Disorders; Speech Disorders; Self-Injurious Behavior; Lesch-Nyhan Syndrome; Childhood-Onset Fluency Disorder; Tourette Syndrome; Gambling; Stuttering | Details |
| Tavapadon | CVL-751; PF-6649751; PF-06649751 | Phase 3 Clinical | Pfizer Inc, Cerevel Therapeutics Llc | Kidney Diseases; Parkinson Disease; Hepatic Insufficiency | Details |
| Thioridazine | TP-21 | Phase 3 Clinical | Novartis Pharma Ag | Schizophrenia; Anxiety Disorders; Carcinoma, Hepatocellular | Details |
| Olanzapine long acting injectable (Teva Pharmaceutical Industries) | TV-44749; TEV-‘749; mdc-TJK | Phase 3 Clinical | Medincell SA | Schizophrenia | Details |
| PF-06412562 | PF-6412562; PF-06412562 | Phase 2 Clinical | Pfizer Inc | Schizophrenia; Schizophrenia Spectrum and Other Psychotic Disorders; Parkinson Disease | Details |
| Mevidalen | LY-3154207 | Phase 2 Clinical | Eli Lilly And Company | Parkinson Disease; Lewy Body Disease | Details |
| TGOF02N | TGOF-02N; TGOF02N; FKF02SC | Phase 2 Clinical | Fabre-Kramer | Schizophrenia | Details |
| ASP-4345 | ASP-4345 | Phase 2 Clinical | Astellas Pharma Inc | Schizophrenia | Details |
| Docarpamine (Martin Pharmaceuticals) | Phase 2 Clinical | Martin Pharmaceuticals Inc | Gastrointestinal Diseases; Liver Cirrhosis; Mouth Diseases | Details | |
| CVL-871 | CVL-871 | Phase 2 Clinical | Pfizer Inc | Dementia | Details |
| [11C]NNC-112 | [11C]NNC-112 | Phase 2 Clinical | Glaxosmithkline Plc | Diagnostic agents | Details |
| Lu-AF-28996 | Phase 1 Clinical | H. Lundbeck A/S | Parkinson Disease | Details | |
| Olanzapine intranasal (Neurelis) | NRL-4; NRL-1004 | Phase 1 Clinical | Neurelis Inc | Bipolar Disorder | Details |
| Oxytocin/Methylergometrine Maleate | Phase 1 Clinical | Nanjing Gritpharma Co Ltd | Hemorrhage; Obstetric Labor Complications | Details | |
| ITI-333 | ITI-333 | Phase 1 Clinical | Intra-Cellular Therapies Inc | Mood Disorders; Pain; Opioid-Related Disorders | Details |
| PF-06730110 | PF-06730110; [18F]MNI-968 | Phase 1 Clinical | Invicro Llc | Nerve Degeneration | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
